Mathews Journal of Pharmaceutical Science (MJPS; ISSN: 2474-753X) is international scholarly journal that publishes original research pertaining to diverse pharmaceutical science related topics, such as pro-drug development, drug delivery, drug action, clinical research, drug stability, dosage form design, rational use of pharmacotherapy, metabolic disposition of bioactive agents, targeted drug delivery, regulatory affairs, pharmaceutical biotechnology, pharmacokinetics, pharmacodynamics, ADME, pharmaceutical analysis, bioequivalence and bioavailability, molecular pharmaceutics, biopharmaceutics, microencapsulation, and protein-peptide chemistry with specific focus on pharmaceutical technology.
Special impetus is placed on papers related to drug safety and dealing with topics, such as pharmacoepidemiology, pharmacovigilance, risk management, benefit-risk assessment, and medication error prevention.
This leading journal on the field of Pharmacy and Pharmacology publishes critical reviews, perspectives, commentaries, and original research articles at the interface of disciplines itemized within pharmaceutical and related sciences, and takes great pride in keeping pace with latest research on how drug action/activity may be optimized using new technologies.
Why publish with us?
High Visibility: MJPS follows open access policy, thereby allowing the published articles to be accesses around the globe.
Promotion in Social Media: MJPS believes that serving the authors includes aggressively promoting their articles on social media platforms, and thereby ensuring them higher visibility.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Pharmaceutical Science. For submission assistance contact: i[email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.
Published : 20th February 2025
Authors : Ezegbe Chekwube Andrew1,3,*, Anikwe Chidera Celestine4, Ezegbe Amarachi Grace2,#, Okafor Nnedimma Pauline1, Odo Kenechi Benjamin1, Onyia Oluebube Chisom1, Agu-kalu Amarachi1, Ugorji Anita Chidera1, Uchenna Chiamaka Precious1, Onoduagu Simeon Chinedu1, Dingwoke Juliet Obianuju1, Onyekwere Favour Ezinne1
Citation : Andrew EC, et al. (2025). Mucoadhesive Polymer-Based Formulations for Drug Delivery. Mathews J Pharma Sci. 9(1):44.
Published : 31st January 2025
Authors : Ferruccio Trifirò1,*, Paolo Zanirato2,#
Citation : Trifirò, et al. (2025). Recent ECHA and POP Restrictions On the Use of Substances from the PFAS Family. Mathews J Pharma Sci. 9(1):42.
Published : 28th January 2025
Authors : B Ravindra Babu*, Mammai Pranitha
Citation : Ravindra Babu B, et al. (2025). Formulation and Evaluation of Solid Lipid Nanoparticles Loaded with Orlistat for Enhanced Oral Bioavailability. Mathews J Pharma Sci. 9(1):43.
Published : 09th January 2025
Authors : Anikwe Chidera Celestine1,2, Ezegbe Chekwube Andrew3,4,*, Ugwu Emmanuel Oforma1, Ogbozor Maduaburochi Christian1, Ozioko Diana Chinenyenwa1, Eneje Jude Chetachukwu1, Ugorji Anita Chidera4, Uchenna Chiamaka Precious4, Onyekwere Favour Ezinne4, Odo Kenechi Benjamin4, Ezugwu Christopher Obodike1
Citation : Celestine AC, et al. (2025). Investigation into the Pharmacognostic and Antimicrobial Properties of the Leaf Extract of Bridelia Ferruginea Benth (Euphorbiaceae). Mathews J Pharma Sci. 9(1):41.
Published : 14th December 2024
Authors : Mohammad Nadeem khan*
Citation : Khan MN. (2024). Cyclotron Technology: Revolutionizing Nuclear Medicine for Geriatric Disorders. Mathews J Pharma Sci. 8(4):43.
Published : 30th November 2024
Authors : Ferruccio Trifirò1, Paolo Zanirato2,*
Citation : Trifirò F, et al. (2024). Water Purification: Physical, Mechanical, Chemical and Biological Treatments. Mathews J Pharma Sci. 8(3):42.